SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-13-003388
Filing Date
2013-08-14
Accepted
2013-08-14 08:30:34
Documents
17
Period of Report
2013-08-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_081413.htm 8-K 26027
2 EXHIBIT 99.1 exh_991.htm EX-99.1 38396
3 EXHIBIT 99.2 exh_992.htm EX-99.2 13197
4 exh992_01.jpg GRAPHIC 100692
5 exh992_02.jpg GRAPHIC 208794
6 exh992_03.jpg GRAPHIC 115367
7 exh992_04.jpg GRAPHIC 126588
8 exh992_05.jpg GRAPHIC 199216
9 exh992_06.jpg GRAPHIC 122513
10 exh992_07.jpg GRAPHIC 157084
11 exh992_08.jpg GRAPHIC 130756
12 exh992_09.jpg GRAPHIC 167540
13 exh992_10.jpg GRAPHIC 363057
14 exh992_11.jpg GRAPHIC 171319
15 exh992_12.jpg GRAPHIC 197337
16 exh992_13.jpg GRAPHIC 140112
17 exh992_14.jpg GRAPHIC 121962
  Complete submission text file 0001171843-13-003388.txt   3280258
Mailing Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281
Business Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281 6022865520
Capstone Therapeutics Corp. (Filer) CIK: 0000887151 (see all company filings)

IRS No.: 860585310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33560 | Film No.: 131035049
SIC: 2834 Pharmaceutical Preparations